Enhanced expression of cyclins and cyclin-dependent kinases in aniline-induced cell proliferation in rat spleen

Toxicology and Applied Pharmacology

Volumn 250, Issue 2, 2011, Pages 213-220

  Wang, Jianling ^a   Wang, Gangduo ^a   Ma, Huaxian ^a   Khan, M Firoze ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Aniline; CDKs; Cell proliferation; Cyclins; PRB; Splenic toxicity

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ACTIN; ANILINE; CYCLIN D1; CYCLIN D2; CYCLIN D3; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN E; CYCLINE; KI 67 ANTIGEN; MESSENGER RNA; MINICHROMOSOME MAINTENANCE PROTEIN; MINICHROMOSOME MAINTENANCE PROTEIN 2; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CARCINOGENIC ACTIVITY; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; IRON OVERLOAD; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SARCOMA; SPLEEN; SPLEEN DISEASE; SPLEEN FIBROSIS; SPLEEN HYPERPLASIA; SPLENOMEGALY; WESTERN BLOTTING;

ANILINE COMPOUNDS; ANIMALS; BLOTTING, WESTERN; CARCINOGENS; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASES; CYCLINS; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; MALE; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SPLEEN;

RATTUS;

EID: 78650530938     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2010.10.026     Document Type: Article

References (56)

1. Bartkova J., Lukas J., Strauss M., Bartek J. Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation. Oncogene 1998, 17:1027-1037.
2. Blow J.J., Hodgson B. Replication licensing-defining the proliferative state?. Trends Cell Biol. 2002, 12:72-78.
3. Brown K.E., Mathahs M.M., Broadhurst K.A., Weydert J. Chronic iron overload stimulates hepatocyte proliferation and cyclin D1 expression in rodent liver. Transl. Res. 2006, 148:55-62.
4. Bus J.S., Popp J.A. Perspectives on the mechanism of action of the splenic toxicity of aniline and structurally-related compounds. Food Chem. Toxicol. 1987, 25:619-626.
5. Chulu J.L., Liu H.J. Recent patents on cell cycle regulatory proteins. Recent Pat. Biotechnol. 2009, 3:1-9.
6. Cobrinik D. Pocket proteins and cell cycle control. Oncogene 2005, 24:2796-2809.
7. Di Girolamo F., Campanella L., Samperi R., Bachi A. Mass spectrometric identification of hemoglobin modifications induced by nitrosobenzene. Ecotoxicol. Environ. Saf. 2009, 72:1601-1608.
8. Emmendoerffer A., Hecht M., Boeker T., Mueller M., Heinrich U. Role of inflammation in chemical-induced lung cancer. Toxicol. Lett. 2000, 112-113:185-191.
9. Goodman D.G., Ward J.M., Reichardt W.D. Splenic fibrosis and sarcomas in F344 rats fed diets containing aniline hydrochloride, p-chloroaniline, azobenzene, o-toluidine hydrochloride, 4, 4'-sulfonyldianiline, or D & C red No. 9. J. Natl. Cancer Inst. 1984, 73:265-273.
10. Harbour J.W., Luo R.X., Dei Santi A., Postigo A.A., Dean D.C. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 1999, 98:859-869.
11. Hatakeyama M., Brill J.A., Fink G.R., Weinberg R.A. Collaboration of G1 cyclins in the functional inactivation of the retinoblastoma protein. Genes Dev. 1994, 8:1759-1771.
12. Hunter T., Pines J. Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age. Cell 1994, 79:573-582.
13. Keyomarsi K., Conte D., Toyofuku W., Fox M.P. Deregulation of cyclin E in breast cancer. Oncogene 1995, 11:941-950.
14. Khan M.F., Kaphalia B.S., Boor P.J., Ansari G.A.S. Subchronic toxicity of aniline hydrochloride in rats. Arch. Environ. Contam. Toxicol. 1993, 24:368-374.
15. Khan M.F., Boor P.J., Gu Y., Alcock N.W., Ansari G.A.S. Oxidative stress in the splenotoxicity of aniline. Fundam. Appl. Toxicol. 1997, 35:22-30.
16. Khan M.F., Wu X., Boor P.J., Ansari G.A.S. Oxidative modification of lipids and proteins in aniline-induced splenic toxicity. Toxicol. Sci. 1999, 48:134-140.
17. Khan M.F., Wu X., Alcock N.W., Boor P.J., Ansari G.A.S. Iron exacerbates aniline-associated splenic toxicity. J. Toxicol. Environ. Health Part A 1999, 57:173-184.
18. Khan M.F., Wu X., Ansari G.A.S., Boor P.J. Malondialdehyde-protein adducts in the spleens of aniline-treated rats: immunochemical detection and localization. J. Toxicol. Environ. Health Part A 2003, 66:93-102.
19. Khan M.F., Wu X., Kaphalia B.S., Boor P.J., Ansari G.A.S. Nitrotyrosine formation in splenic toxicity of aniline. Toxicology 2003, 194:95-102.
20. Khan M.F., Kannan S., Wang J. Activation of transcription factor AP-1 and mitogen-activated protein kinases in aniline-induced splenic toxicity. Toxicol. Appl. Pharmacol. 2006, 210:86-93.
21. Kinoshita A., Wanibuchi H., Wei M., Yunoki T., Fukushima S. Elevation of 8-hydroxydeoxyguanosine and cell proliferation via generation of oxidative stress by organic arsenicals contributes to their carcinogenicity in the rat liver and bladder. Toxicol. Appl. Pharmacol. 2007, 221:295-305.
22. Korkolopoulou P., Givalos N., Saetta A., Goudopoulou A., Gakiopoulou H., Thymara I., Thomas-Tsagli E., Patsouris E. Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators. Hum. Pathol. 2005, 36:899-907.
23. Lei M. The MCM complex: its role in DNA replication and implications for cancer therapy. Curr. Cancer Drug Targets 2005, 5:365-380.
24. Lundberg A.S., Weinberg R.A. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-CDK complexes. Mol. Cell. Biol. 1998, 18:753-761.
25. Lundberg A.S., Weinberg R.A. Control of the cell cycle and apoptosis. Eur. J. Cancer 1999, 35:531-539.
26. Lyons A.B. Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J. Immunol. Meth. 2000, 243:147-154.
27. Ma H., Wang J., Abdel-Rahman S.Z., Boor P.J., Khan M.F. Oxidative DNA damage and its repair in rat spleen following subchronic exposure to aniline. Toxicol. Appl. Pharmacol. 2008, 233:247-253.
28. Malumbres M., Barbacid M. To cycle or not to cycle: a critical decision in cancer. Nat. Rev. Cancer 2001, 1:222-231.
29. Malumbres M., Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat. Rev. Cancer 2009, 9:153-166.
30. Matsushime H., Ewen M.E., Strom D.K., Kato J.Y., Hanks S.K., Roussel M.F., Sherr C.J. Identification and properties of an atypical catalytic subunit (p34PSKJ3/CDK4) for mammalian D-type GI cyclins. Cell 1992, 71:323-334.
31. Menon S.G., Goswami P.C. A redox cycle within the cell cycle: ring in the old with the new. Oncogene 2007, 26:1101-1109.
32. Meyerson M., Harlow E. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 1994, 14:2077-2086.
33. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 1983, 65:55-63.
34. Murray A.W. Recycling the cell cycle: cyclins revisited. Cell 2004, 116:221-234.
35. Muul L.M., Silvin C., James S.P., Candotti F. Measurement of proliferative responses of cultured lymphocytes. Curr. Protoc. Immunol. 2008, Chapter 7: Unit 7.10.1-7.10.24.
36. Olashaw N., Pledger W.J. Paradigms of growth control: relation to Cdk activation. Sci. STKE 2002, 2002:1-14.
37. Olguín-Martínez M., Mendieta-Condado E., Contreras-Zentella M., Escamilla J.E., Aranda-Fraustro A., El-Hafidi M., Hernández-Muñoz R. Rate of oxidant stress regulates balance between rat gastric mucosa proliferation and apoptosis. Free Radic. Biol. Med. 2006, 41:1325-1337.
38. Pardee A.B. G1 events and regulation of cell proliferation. Science 1989, 246:603-608.
39. Park D.H., Shin J.W., Park S.K., Seo J.N., Li L., Jang J.J., Lee M.J. Diethylnitrosamine (DEN) induces irreversible hepatocellular carcinogenesis through overexpression of G1/S-phase regulatory proteins in rat. Toxicol. Lett. 2009, 191:321-326.
40. Pauluhn J. Subacute inhalation toxicity of aniline in rats: analysis of time-dependence and concentration-dependence of hematotoxic and splenic effects. Toxicol. Sci. 2004, 81:198-215.
41. Pietrangelo A. Iron-induced oxidant stress in alcoholic liver fibrogenesis. Alcohol 2003, 30:121-129.
42. Sarsour E.H., Kumar M.G., Chaudhuri L., Kalen A.L., Goswami P.C. Redox control of the cell cycle in health and disease. Antioxid. Redox Signal. 2009, 11:2985-3011.
43. Scholzen T., Gerdes J. The Ki-67 protein: from the known and the unknown. J. Cell. Physiol. 2000, 182:311-322.
44. Sherr C.J. D-type cyclins. Trends Biochem. Sci. 1995, 20:187-190.
45. Sherr C.J. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res. 2000, 60:3689-3695.
46. Sherr C.J., Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999, 13:1501-1512.
47. Sicinska E., Aifantis I., Le Cam L., Swat W., Borowski C., Yu Q., Ferrando A.A., Levin S.D., Geng Y., von Boehmer H., Sicinski P. Requirement for cyclin D3 in lymphocyte development and T cell leukemias. Cancer Cell 2003, 4:451-461.
48. Sington J.D., Freeman A., Morris L.S., Vowler S.L., Arch B.N., Fisher C., Coleman N. Minichromosome maintenance protein in myxofibrosarcoma. Mod. Pathol. 2004, 17:235-240.
49. Stuart-Harris R., Caldas C., Pinder S.E., Pharoah P. Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32, 825 patients. Breast 2008, 17:323-334.
50. Swenberg J.A., Barrow C.S., Boreiko C.J., Heck H.D., Levine R.J., Morgan K.T., Starr T.B. Non-linear biological responses to formaldehyde and their implications for carcinogenic risk assessment. Carcinogenesis 1983, 4:945-952.
51. Wang J., Kannan S., Li H., Khan M.F. Cytokine gene expression and activation of NF-kappa B in aniline-induced splenic toxicity. Toxicol. Appl. Pharmacol. 2005, 203:36-44.
52. Wang J., Wang G., Ansari G.A.S., Khan M.F. Activation of oxidative stress-responsive signaling pathways in early splenotoxic response of aniline. Toxicol. Appl. Pharmacol. 2008, 230:227-234.
53. Wang J., Ma H., Boor P.J., Ramanujam V.M., Ansari G.A.S., Khan M.F. Up-regulation of heme oxygenase-1 in rat spleen after aniline exposure. Free Radic. Biol. Med. 2010, 48:513-518.
54. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell 1995, 81:323-330.
55. Weinberger M.A., Albert R.H., Montgomery S.B. Splenotoxicity associated with splenic sarcomas in rats fed high doses of D & C Red No. 9 or aniline hydrochloride. J. Natl. Cancer Inst. 1985, 75:681-690.
56. Williams G.M., Iatropoulos M.J. Alteration of liver cell function and proliferation: differentiation between adaptation and toxicity. Toxicol. Pathol. 2002, 30:41-53.